Business
Below is a brief description of our significant business relationships and collaborations and related license agreements that expand our pipeline and provide us with certain rights to existing and potential new products and technologies.
INCYTE CORP: Revenue grew 21.2% to $5.141B from $4.241B. Net income grew 3845.0% to $1.287B from $32.615M. Free cash flow grew 372.6% to $1.355B from $286.637M. Operating margin expanded 2801 bps to 29.46%. INCYTE CORP's annual comparison also shows inventory grew faster than revenue.
The read at a glance✓ Audited against SEC data
- Growth — Revenue grew 21.2%OK
- Profitability — Net income grew 3845.0% to $1.287B from $32.615MOK
- Cash flow — Free cash flow grew 372.6% to $1.355B from $286.637MOK
- Margins — Operating margin expanded 2801 bps to 29.46%OK
- Accounting — No overriding statistical warningNote
- Insiders — 0 purchases and 30 salesWatch
Where the revenue comes from
Fiscal 2025, as INCYTE CORP reports it. History and quarterly detail are in the app.
- Product revenues, net$4.4B
- Product royalty revenues$636.9M
- JAKAVI$457.7M
- Milestone and contract revenues$150.0M
- OLUMIANT$144.6M
Leadership changes
From INCYTE CORP's own filings, the day they're filed.
- Susanne Schaffert · Directors · departureeff. 2026-04-15
- Herv Hoppenot · Chief Executive Officer · departureeff. 2025-12-10
- Thomas Tray · Chief Accounting Officer · appointmenteff. 2025-09-16
Latest filings
- 8-K · Company announcement2026-08-31
- 10-Q · Quarterly report2026-07-28
- 8-K · Company announcement2026-07-28
- 8-K · Company announcement2026-07-06
- 8-K · Company announcement2026-06-22
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about INCYTE CORP, every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.